(Q71671957)
Statements
Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology (English)
K Schmiegelow
H Schrøder
G Gustafsson
J Kristinsson
A Glomstein
T Salmi
1 February 1995